Cargando…
Protection against renal ischemia–reperfusion injury in vivo by the mitochondria targeted antioxidant MitoQ
Ischemia–reperfusion (IR) injury to the kidney occurs in a range of clinically important scenarios including hypotension, sepsis and in surgical procedures such as cardiac bypass surgery and kidney transplantation, leading to acute kidney injury (AKI). Mitochondrial oxidative damage is a significant...
Autores principales: | Dare, Anna J., Bolton, Eleanor A., Pettigrew, Gavin J., Bradley, J. Andrew, Saeb-Parsy, Kourosh, Murphy, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427662/ https://www.ncbi.nlm.nih.gov/pubmed/25965144 http://dx.doi.org/10.1016/j.redox.2015.04.008 |
Ejemplares similares
-
The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model
por: Dare, Anna J., et al.
Publicado: (2015) -
Mitochondria-targeted antioxidant therapy with MitoQ ameliorates aortic stiffening in old mice
por: Gioscia-Ryan, Rachel A., et al.
Publicado: (2018) -
The mitochondria-targeted antioxidant MitoQ, attenuates exercise-induced mitochondrial DNA damage
por: Williamson, Josh, et al.
Publicado: (2020) -
Mitochondria‐targeted antioxidant MitoQ reduced renal damage caused by ischemia‐reperfusion injury in rodent kidneys: Longitudinal observations of T
(2)‐weighted imaging and dynamic contrast‐enhanced MRI
por: Liu, Xiaoge, et al.
Publicado: (2017) -
Combined therapeutic benefit of mitochondria-targeted antioxidant, MitoQ(10), and angiotensin receptor blocker, losartan, on cardiovascular function
por: McLachlan, Jennifer, et al.
Publicado: (2014)